Corsano specializes in advanced real-time remote patient monitoring solutions. Medtronic agreed to exclusively distribute the company’s wearable solution in Western Europe for hospital and hospital-at-home use. The company says it enhances remote monitoring capabilities and transforms patient care across healthcare settings.
The state-of-the-art Corsano wearable delivers continuous monitoring of vital signs. Features include heart rate, breathing rate, SpO2, cuffless non-invasive blood pressure monitoring and ECG. It provides clinicians with seamless, real-time data to non-invasively monitor patients anytime, anywhere.
Medtronic said the Corsano technology supports the principles of value-based healthcare, aligning with its mission. Corsano Health CEO Peter Stas says the distribution deal can help redefine connected care models and support healthcare systems’ evolving needs.
According to Medtronic, the Corsano solution also provides unrestricted access to raw data for AI development.
“The Corsano multi-parameter wearable will enhance our portfolio of patient monitoring solutions and help to protect more patients in more places. This innovation empowers our healthcare professionals with real-time tracking and predictive analytics designed to inform clinician decision-making. With the Corsano multi-parameter wearable solution, clinicians instantly connect to real-time patient data through a powerful, flexible monitoring platform. It is a scalable, future-ready solution for hospitals seeking to modernize care by maximizing their monitoring functionality. Together, we are transforming the healthcare landscape, turning aspirations into reality, and forging a future where safety and excellence go hand in hand,” said Marc De Martini, VP, Western Europe Commercial, Acute Care and Monitoring business at Medtronic.
